RECRUITINGOBSERVATIONAL
Clinical and Laboratory Characteristics of a Population of Children and Adolescents With Newly Diagnosed Type 1 Diabetes and Insulin Requirements at Onset
About This Trial
The clinical implication of this study lies in the identification of factors that may predict reduced insulin sensitivity in children and adolescents at the onset of Type 1 Diabetes and would help the physician to undertake appropriate therapy more quickly by achieving the correct therapeutic dosage, in order to achieve good metabolic compensation at an early stage and thus reduce the time (and costs) of hospitalisation.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age ≤ 14 years at the time of diagnosis of type 1 diabetes;
- Diagnosis of type 1 diabetes confirmed between January 2014 and December 2018 at the Pediatrics Unit of the IRCCS Azienda Ospedaliero-Universitaria of Bologna, Italy;
- Patients with at least 1 year of follow-up after diagnosis od type 1 diabetes;
- Obtaining willing to sign a consent form from parents/legal guardian of pediatric patients.
Who Should NOT Join This Trial:
- Patients with diabetes other that type 1;
- Patients followed at other centres at the time of onset of type 1 diabetes.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age ≤ 14 years at the time of diagnosis of type 1 diabetes;
* Diagnosis of type 1 diabetes confirmed between January 2014 and December 2018 at the Pediatrics Unit of the IRCCS Azienda Ospedaliero-Universitaria of Bologna, Italy;
* Patients with at least 1 year of follow-up after diagnosis od type 1 diabetes;
* Obtaining informed consent from parents/legal guardian of pediatric patients.
Exclusion Criteria:
* Patients with diabetes other that type 1;
* Patients followed at other centres at the time of onset of type 1 diabetes.
Locations (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy